Novo Nordisk: Transaction in Own Shares

BAGSVAERD, DENMARK, Oct 05 (MARKET WIRE) --
Novo Nordisk A/S - Share repurchase programme

On 7 August 2009 Novo
Nordisk initiated its share repurchase programme in accordance with the
provisions of the European Commission's regulation no 2273/2003 of 22
December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount
up to DKK 2.4 billion in the period from 10 August 2009 to 18 December
2009.

Since the announcement as of 28 September 2009, the following
transactions have been made under the programme:

Number of Average Transaction
shares purchase price value, DKK
Accumulated, last
announcement 2,682,500 853,849,597
28 September 2009 70,000 320.8900 22,462,300
29 September 2009 59,500 321.9410 19,155,490
30 September 2009 75,000 318.8990 23,917,425
1 October 2009 75,000 317.6710 23,825,325
2 October 2009 70,000 319.9301 22,395,107
Accumulated under
the programme 3,032,000 965,605,244

With the transactions stated above, Novo Nordisk owns a total of
27,868,808 treasury shares, corresponding to 4.5% of the share capital.
The total amount of shares in the company is 620,000,000 including
treasury shares.

Correction:

In the company announcement as of 28 September 2009 related to the share
repurchase programme, the dates in the table were not updated properly.
All numbers and ownership figures were however correct.

Novo Nordisk is a healthcare company and a world leader in diabetes care.
In addition, Novo Nordisk has a leading position within areas such as
haemostasis management, growth hormone therapy and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical products
and services that make a significant difference to patients, the medical
profession and society. With headquarters in Denmark, Novo Nordisk
employs more than 28,500 employees in 81 countries, and markets its
products in 179 countries. Novo Nordisk's B shares are listed on the
stock exchanges in Copenhagen and London. Its ADRs are listed on the New
York Stock Exchange under the symbol 'NVO'. For more information,
visit
novonordisk.com.

Further information:

Media: Investors:

Outside North America: Outside North America:
Mette Kruse Danielsen Mads Veggerby Lausten
Tel: (+45) 4442 3883 Tel: (+45) 4443 7919
mkd@novonordisk.com mlau@novonordisk.com

Kasper Roseeuw Poulsen
Tel: 4442 4471
krop@novonordisk.com

In North America: In North America:
Sean Clements Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com hrmm@novonordisk.com

Company Announcement no 59 / 2009

This announcement was
originally distributed by Hugin. The issuer is solely responsible for the
content of this announcement.

Copyright Copyright Hugin AS 2009. All
rights reserved.

Copyright 2009, Market Wire, All rights reserved.

-0-